4 November 2016
SpeeDx Receives CE-IVD Mark for ResistancePlus™ MG
SpeeDx Pty. Ltd. has received CE-IVD marking for its ResistancePlus® MG assay that detects both the sexually transmitted disease (STD)...
5 October 2016
SpeeDx Receives TGA Approval for PlexPCR™ HSV-1&2, VZV
SpeeDx Pty. Ltd. has received TGA approval for its PlexPCR® HSV-1&2, VZV multiplex qPCR kit. The test offers a single-well...
15 September 2016
For Drug-Resistant STIs, Detection Is Not Enough
A recent article posted in Clinical Lab Products (CLP) by Professor Sepehr Tabrizi, Royal Women’s Hospital, Melbourne, describes our current...
29 June 2016
SpeeDx Receives CE-IVD Mark for PlexPCR® HSV-1&2, VZV
SpeeDx has received CE-IVD marking for its PlexPCR® HSV-1&2, VZV multiplex qPCR kit. The new multiplex molecular diagnostic test offers a...
23 June 2016
First publication for ResistancePlus MG
Announcing the first publication for our ResistancePlus® MG assay, published in PLOS ONE in collaboration with Sepehr Tabrizi, PhD at...
15 June 2016
SpeeDx ResistancePlus MG featured in GenomeWeb article
SpeeDx are featured in a great article in GenomeWeb discussing Mycoplasma genitalium, and the antibiotic resistance status of this significant sexually transmitted...
